MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,083 | +5.6% | 2,719 | -53.0% | 0.05% | +75.9% |
| Q3 2022 | $376,000 | +57.3% | 5,789 | +73.1% | 0.03% | +45.0% |
| Q2 2022 | $239,000 | -34.3% | 3,345 | -26.7% | 0.02% | -54.5% |
| Q3 2021 | $364,000 | -67.4% | 4,564 | -60.2% | 0.04% | -74.3% |
| Q2 2021 | $1,118,000 | +26.9% | 11,478 | +52.3% | 0.17% | -11.4% |
| Q1 2021 | $881,000 | -25.1% | 7,535 | -28.8% | 0.19% | -47.8% |
| Q4 2020 | $1,177,000 | – | 10,588 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |